Xspray Pharma prepares for listing on main list
STOCKHOLM, SWEDEN – October 25, 2018. Xspray Pharma (Nasdaq First North: XSPRAY) today announced the decision of the company's board of directors that Xspray will apply for listing of the company's share on Nasdaq Stockholm's main list. The list change is expected to take place within 12 months and is made to improve the prerequisites for a broader ownership base.The company's board and management will now initiate the work required to prepare the company for listing on the main list. The goal is to complete the up-listing within the next twelve months. "We feel that Xspray is mature for